Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Oracle Corporation (ORCL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indivior Pharmaceuticals Inc. Common Stock vs Oracle Corporation — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Oracle Corporation trades at $128.3 (market cap $434.11B). The key difference: Oracle Corporation is far larger — about 103.9× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Oracle Corporation pays a 1.4% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Oracle Corporation for 73 Days on average.
| INDV | ORCL | |
|---|---|---|
Market Cap | $4.18B | $434.11B |
Volume | 1,819,746 | 25,917,551 |
Sector | Health | Technology |
52-Week High | $41.83 | $313.00 |
52-Week Low | $24.09 | $114.99 |
Typical Hold Time | 0 Days | 73 Days |
Enterprise Value | $4.47B | $557.92B |
Dividend Yield | — | 1.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Oracle (ORCL) trades at $143.22, up 4.24% today, but faces a bearish technical signal with the stock near support at $135. The company reported strong Q1 2026 earnings, beating EPS estimates with $2.11 versus $1.96 expected, and maintains robust profitability with a 26.36% net income margin. Revenue growth accelerated to $57.4 billion in 2025, up from $53.0 billion in 2024, driven by AI cloud demand.
Outlook remains positive given analyst consensus price target of $236.52, implying significant upside, but risks include high debt levels and sensitivity to Fed policy. The stock's current valuation at a P/E of 22.45 appears reasonable relative to earnings growth, though investor sentiment is cautious amid recent layoffs and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indivior Pharmaceuticals Inc. Common Stock
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Read more on ORCL →
